Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 73.00
-0.90 (-1.22%)
Sep 11, 2025, 5:24 PM IDT
TLV:GEFR Revenue
Geffen Residence & Renewal had revenue of 19.00K ILS in the quarter ending June 30, 2025, a decrease of -97.01%. This brings the company's revenue in the last twelve months to -501.00K, down -137.33% year-over-year. In the year 2024, Geffen Residence & Renewal had annual revenue of 131.00K, down -7.75%.
Revenue (ttm)
-501.00K
Revenue Growth
-137.33%
P/S Ratio
-305.64
Revenue / Employee
-23.86K
Employees
21
Market Cap
153.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.00K | -11.00K | -7.75% |
| Dec 31, 2023 | 142.00K | 82.00K | 136.67% |
| Dec 31, 2022 | 60.00K | -598.00K | -90.88% |
| Dec 31, 2021 | 658.00K | -2.01M | -75.33% |
| Dec 31, 2020 | 2.67M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.84B |
| Kamada | 571.15M |
| BrainsWay | 155.27M |
| SofWave Medical | 234.12M |
| Bait Bakfar | 106.25M |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 922.54M |